Repligen Corporation (RGEN)
NASDAQ·Healthcare·Medical - Instruments & Supplies
$112.64
-4.08%
Mkt Cap $7.02B
Analyst Ratings
Buy
10
Hold
1
Sell
0
Price Target (18 analysts)
$183.00
Range $160.00 – $200.00
Implied Upside
+62.5%
Consensus $183.00 vs current $112.64